From: Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma
Variable | HR | 95% CI | P value | HR | 95% CI | P value |
---|---|---|---|---|---|---|
Age | 1.030 | 0.966–1.099 | 0.366 | |||
Sex | 0.796 | |||||
Female | Reference | |||||
Male | 1.181 | 0.333–4.189 | ||||
Tumor diameter | 0.854 | 0.352–2.371 | 0.914 | |||
Smoking status | 0.355 | |||||
No/unknown | Reference | |||||
Yes | 2.077 | 0.441–9.786 | ||||
Surgical type | 0.985 | |||||
Lobectomy | Reference | |||||
Limited | 1.015 | 0.214–4.807 | ||||
Histology subtype | 0.894 | |||||
Lepidic | Reference | |||||
Acinar/papillary | 1.646 | 0.209–12.996 | ||||
Mircopapillary/solid | < 0.001 | – | ||||
Solid component ratio | 0.017 | 0.017 | ||||
0 | Reference | Reference | ||||
≤ 50% | > 100 | 0.001- > 100 | > 100 | 0.001- > 100 | ||
> 50% | > 100 | 0.001- > 100 | > 100 | 0.001- > 100 |